Upexi Secures $7.4M in Registered Direct Offering at Premium, Amends Existing Warrants

summarizeSummary

Upexi, Inc. announced the pricing of a registered direct offering, raising $7.4 million by selling 6.3 million shares and accompanying warrants at $1.17 per unit, a premium to its current stock price. Concurrently, the company amended existing warrants, lowering their exercise price.

check_boxKey Events · Financing and Capital Events · UPXI

• Secured $7.4 Million in Capital

  Upexi, Inc. raised $7.4 million in gross proceeds through a registered direct offering of 6,337,000 shares of common stock and accompanying warrants.

• Offering Priced at Premium to Market

  The combined offering price was $1.17 per share and accompanying warrant, which is above the current stock price of $1.06, indicating institutional interest.

• Existing Warrants Amended

  Warrants issued in December 2025 for 3,289,474 shares had their exercise price reduced from $4.00 to $2.83 and their redemption trigger lowered from $8.50 to $7.00, increasing potential dilution for existing shareholders.

• Short Lock-Up and Equity Sales Restriction

  Directors and executive officers are subject to a 15-day lock-up, and the company has a 15-day restriction on new equity issuances, with exceptions for its existing At-The-Market (ATM) program.

auto_awesomeAnalysis · UPXI · Crypto Assets

This 8-K finalizes the terms and pricing of a registered direct offering, which closed on February 9, 2026, as previously indicated by a 424B5 filing. The company successfully raised $7.4 million in gross proceeds by issuing 6,337,000 shares and an equal number of accompanying warrants. Notably, the combined offering price of $1.17 per unit is at a premium to the current market price of $1.06, demonstrating institutional confidence and providing crucial capital for general corporate purposes and its Solana (SOL) maximum return strategy. However, the offering introduces substantial dilution, representing a significant portion of the company's market capitalization. Furthermore, the company amended previously issued warrants from December 2025, reducing their exercise price from $4.00 to $2.83 and the redemption trigger from $8.50 to $7.00. This amendment makes those existing warrants more favorable for the holder and increases potential future dilution for current shareholders. The offering also includes a short 15-day lock-up for insiders and a 15-day restriction on further equity sales, with exceptions for the existing at-the-market (ATM) program, suggesting ongoing capital needs. This financing follows recent disclosures of a large ATM offering and a resale registration, indicating a continuous effort to secure liquidity.